chr3-4516132-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001378452.1(ITPR1):​c.-16-344G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00892 in 152,290 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0089 ( 23 hom., cov: 33)

Consequence

ITPR1
NM_001378452.1 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.584

Publications

0 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 3-4516132-G-A is Benign according to our data. Variant chr3-4516132-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1193683.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00892 (1359/152290) while in subpopulation AFR AF = 0.0307 (1276/41556). AF 95% confidence interval is 0.0293. There are 23 homozygotes in GnomAd4. There are 611 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378452.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
NM_001378452.1
MANE Select
c.-16-344G>A
intron
N/ANP_001365381.1Q14643-1
ITPR1
NM_001168272.2
c.-16-344G>A
intron
N/ANP_001161744.1Q14643-2
ITPR1
NM_001099952.4
c.-16-344G>A
intron
N/ANP_001093422.2Q14643-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
ENST00000649015.2
MANE Select
c.-16-344G>A
intron
N/AENSP00000497605.1Q14643-1
ITPR1
ENST00000354582.12
TSL:5
c.-16-344G>A
intron
N/AENSP00000346595.8A0A3F2YNW8
ITPR1
ENST00000648266.1
c.-16-344G>A
intron
N/AENSP00000498014.1A0A3B3IU04

Frequencies

GnomAD3 genomes
AF:
0.00888
AC:
1352
AN:
152172
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0306
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.00717
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00892
AC:
1359
AN:
152290
Hom.:
23
Cov.:
33
AF XY:
0.00820
AC XY:
611
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0307
AC:
1276
AN:
41556
American (AMR)
AF:
0.00320
AC:
49
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68026
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
67
134
202
269
336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00721
Hom.:
2
Bravo
AF:
0.0102
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
2.2
DANN
Benign
0.68
PhyloP100
0.58
PromoterAI
-0.044
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141017017; hg19: chr3-4557816; API